Google started rolling out the first Quarterly Platform Release beta (QPR1) of Android 14 to Pixel phones. With...
The peer-to-peer (P2) worm known as P2PInfect has witnessed a surge in activity since late August 2023, witnessing a...
A malicious actor released a fake proof-of-concept (PoC) exploit for a recently disclosed WinRAR vulnerability on GitHub...
SoftBank-backed Meesho aims for three-fold growth in orders in the upcoming festive season as it will leverage...
Movie tickets in Indian theatres will cost just Rs. 99 on October 13, in celebration of National...
Security teams are familiar with threats emanating from third-party applications that employees add to improve their productivity....
Assassin’s Creed Mirage’s PC system requirements are out now. Running the game on Ultra settings does not...
China's Ministry of State Security (MSS) has accused the U.S. of breaking into Huawei's servers, stealing critical...
A financially motivated threat actor has been outed as an initial access broker (IAB) that sells access...
Samsung Galaxy S23 FE is expected to launch soon. It is said to succeed the Galaxy S21...
Flipkart's Big Billion Days Sale 2023 is just around the corner. The sale dates are not confirmed...
Motorola Edge 40 Neo 5G has been launched in India. It sports a hole-punch display with 144Hz...
The maintainers of Free Download Manager (FDM) have acknowledged a security incident dating back to 2020 that...
iPhone 15 series reportedly has a new option that limits the charging of its battery to 80...
Oppenheimer won’t be available to stream as VOD until late November, producer Emma Thomas confirmed in an...
Some of the biggest game developers in Japan say trends like generative AI and virtual reality/augmented reality headsets...
Amazon.com is scrapping a plan to charge merchants who do not use its shipping services an additional...
Dall-E 3 will be available to ChatGPT Plus and Enterprise customers in October via the API, the...
The new models won't be a major surprise, as Apple's wearable still excels at fitness tracking and...
Neurotech startup Neuralink has received approval to begin recruiting patients for its first in-human clinical trial.
